Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital
Launched by ASSIUT UNIVERSITY · Apr 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how kidney health is affected in patients who have liver cirrhosis, a serious liver disease. The researchers want to understand how common kidney problems are in these patients and what happens to them in the short term after they are diagnosed. The study is not yet recruiting participants, but it aims to include patients with liver cirrhosis who are admitted to the hospital.
To be part of the trial, patients must have liver cirrhosis but should not have any existing chronic kidney disease beforehand. This means that if someone has had kidney problems for a while, they would not be eligible to join. Participants can expect to undergo tests and evaluations to help the researchers gather information about their kidney function and overall health during their hospital stay. This study is important because it could help improve care for patients with liver cirrhosis by understanding how their kidneys are affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with liver cirrhosis admitted to the department .
- Exclusion Criteria:
- • 1. Patients with known preexisting chronic kidney disease according to KDIGO and EASL 2018 definitions ( defined as functional GFR \<60 ml/min per 1.73 m 2 for ≥3 months or structural kidney damage for ≥3 months ).
- • 2. Patient refusal to give informed consent ( or his first degree relatives in case of disturbed conscious level).
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Assuit, Egypt
Patients applied
Trial Officials
Mohamed Omar Abd El-Malek, professor
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported